NCT05385263 2022-05-26Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at LymphodepletionTel-Aviv Sourasky Medical CenterPhase 2 Unknown20 enrolled